Cardiovascular Advances in Research and Opportunities Legacy Act

United States117th CongressS-1133Senate
Updated: Apr 15, 2021

Summary

Cardiovascular Advances in Research and Opportunities Legacy Act This bill expands research on valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart. The National Institutes of Health must consult with the National Heart, Lung, and Blood Institute to conduct or support research on the disease, including on mitral valve prolapse. This occurs when the valve between the chambers of the left side of the heart seals improperly. The Centers for Disease Control and Prevention (CDC) must develop best practices to treat valvular heart disease. The CDC may also carry out other projects to increase awareness of and reduce deaths from the disease.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

HR-1193: Cardiovascular Advances in Research and Opportunities Legacy Act

Signed by President.

  1. Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1984; text: CR S1985)

    Senate

  2. Introduced in Senate

All available records shown.